Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Common Stock | Options Exercise | +61.6K | +25.53% | 303K | Feb 22, 2023 | Direct | F1 | ||
holding | PGEN | Common Stock | 83K | Feb 22, 2023 | By Trust | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Restricted Stock Units | Options Exercise | $0 | -61.6K | -100% | $0.00* | 0 | Feb 22, 2023 | Common Stock | 61.6K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
F2 | Shares held in the Robert B. Shapiro Revocable Trust. |
F3 | The RSUs vested in full on February 22, 2023. |